0001604586-23-000004.txt : 20230117 0001604586-23-000004.hdr.sgml : 20230117 20230117170214 ACCESSION NUMBER: 0001604586-23-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230117 DATE AS OF CHANGE: 20230117 EFFECTIVENESS DATE: 20230117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RxRevu, Inc. CENTRAL INDEX KEY: 0001604586 IRS NUMBER: 463578999 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-470936 FILM NUMBER: 23532129 BUSINESS ADDRESS: STREET 1: 2601 BLAKE STREET, SUITE 450 CITY: DENVER STATE: CO ZIP: 80205 BUSINESS PHONE: 800-360-4965 MAIL ADDRESS: STREET 1: 2601 BLAKE STREET, SUITE 450 CITY: DENVER STATE: CO ZIP: 80205 D 1 primary_doc.xml X0708 D LIVE 0001604586 RxRevu, Inc. 3001 Brighton Blvd., Suite 103 DENVER CO COLORADO 80216 800-360-4965 DELAWARE None None Corporation true Steve Lindseth 3001 Brighton Blvd., Suite 103 Denver CO COLORADO 80216 Executive Officer Director Kyle Kiser 3001 Brighton Blvd., Suite 103 DENVER CO COLORADO 80216 Executive Officer Director Aaron Cornell 3001 Brighton Blvd., Suite 103 DENVER CO COLORADO 80216 Executive Officer Toby Cosgrove 3001 Brighton Blvd., Suite 103 DENVER CO COLORADO 80216 Director Andrew Firlik 3001 Brighton Blvd., Suite 103 DENVER CO COLORADO 80216 Director Daniel Galles 3001 Brighton Blvd., Suite 103 DENVER CO COLORADO 80216 Director Albert Prast 3001 Brighton Blvd., Suite 103 DENVER CO COLORADO 80216 Director Stephen McHale 3001 Brighton Blvd., Suite 103 DENVER CO COLORADO 80216 Director Richard Zane 3001 Brighton Blvd., Suite 103 DENVER CO COLORADO 80216 Director Benton Barney 3001 Brighton Blvd., Suite 103 DENVER CO COLORADO 80216 Executive Officer Christie Callahan 3001 Brighton Blvd., Suite 103 DENVER CO COLORADO 80216 Executive Officer Lew Parker 3001 Brighton Blvd., Suite 103 DENVER CO COLORADO 80216 Executive Officer Other Health Care Decline to Disclose 06b false 2022-12-30 false true false 0 10000000 6000000 4000000 false 1 0 0 0 false RxRevu, Inc. /s/ Kyle Kiser Kyle Kiser Chief Executive Officer 2023-01-17